Difference between revisions of "Eluvixtamab (AMG-330)"
Jump to navigation
Jump to search
m (Jwarner moved page AMG 330 to Eluvixtamab (AMG 330)) |
m |
||
| Line 1: | Line 1: | ||
| − | =Mechanism of action= | + | ==Mechanism of action== |
Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3 | Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3 | ||
| + | |||
| + | ==Also known as== | ||
| + | *'''Code name:''' AMG 330 | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
Revision as of 12:21, 4 December 2022
Mechanism of action
Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3
Also known as
- Code name: AMG 330